ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non–Small-Cell Lung Cancer: Expert Panel on Radiation Oncology

ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non–Small-Cell Lung Cancer: Expert Panel on Radiation Oncology–Lung

Published:2010-11 Issue:4 Volume:78 Page:969-974
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Gopal Ramesh S.,Dubey Sarita,Rosenzweig Kenneth E.,Chang Joe Yujiao,Decker Roy,Gewanter Richard M.,Kong Feng-Ming,Lally Brian E.,Langer Corey J.,Lee Hoon Ku,Movsas Benjamin

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference24 articles.

1. Multimodality therapy for stage IIIA (N2) lung cancer: An overview;Ginsberg;Chest,1993

2. Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer;van Klaveren;Ann Thorac Surg,1993

3. Results of surgical treatment in patients with stage IIIA non–small-cell lung cancer;Watanabe;Thorac Cardiovasc Surg,1991

4. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung;N Engl J Med,1986

5. Postoperative radiotherapy in non–small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials;Lancet,1998

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report;BMC Pulmonary Medicine;2022-02-05

2. Heterogeneity of stage IIIA non-small cell lung cancer—different tumours, different nodal status, different treatment, different prognosis: a narrative review;Current Challenges in Thoracic Surgery;2021-01

3. Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer;Oncotarget;2017-05-23

4. Optimal sequencing of postoperative radiotherapy and chemotherapy in IIIA-N2 non-small cell lung cancer;Journal of Thoracic Disease;2016-07

5. Sequencing postoperative radiotherapy and adjuvant chemotherapy in non-small cell lung cancer: unanswered questions on the not evidence-based approach;Journal of Thoracic Disease;2016-07